 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
The European Pathway Association is performing an international Cluster Randomised Controlled Trial on the effect of care pathways for COPD and Fractured Neck of Femus patients.
The study is actually performed in Belgium, Ireland, Italy and Portugal. We measure proces and clinical outcomes on patient level and include also indicators on the teamwork.
3 research fellows will perform a PhD study within the EQCP project:
Mrs. Cathy Lodewijckx: The impact of care pathways for COPD patients.
Dr. Fabrizio Leigheb: The impact of care pathways for proximal femur fracture patients.
Mr. Svin Deneckere: The impact of care pathways on teamwork.
You can always contact Kris Vanhaecht who is the international coordinator of the study for more information.
|
|
|
|
|
|
EQCP study design
|
|
|
|
|
|
=====================================================================
=====================================================================
The European Pathway Association performed an international survey in 23 countries on the prevalence and use of pathways.
The results of this research project are internationally published:
Kris Vanhaecht, Marcus Bollmann, Kathy Bower, Clare Gallagher, Andrea Gardini, Jen Guezo, Uwe Jansen, Rashad Massoud, Karen Moody, Walter Sermeus, Ruben Van Zelm, Claire Whittle, Anne-Marie Yazbeck, Karen Zander, Massimiliano Panella (2006). Prevalence and use of clinical pathways in 23 countries — an international survey by the European Pathway Association (www.E-P-A.org). Journal of Integrated Care Pathways, 10, 28-34.
|
|
|
|
|
|
EPA Survey 23 countries participated
|
|
|
|
|
|
Prevalence and use of care pathways Results on 3 questions: 1) Actual Use, 2) Possible use, 3) Use in 5 years
|
|
|
|
|
|
EPA survey Conclusion: there is a future for care pathways, but we only yust begun !
|
|
|
|
|
|
A PDF VERSION OF THE SLIDESHOW WITH ALL RESULTS IS AVAILABLE FOR OUR MEMBERS
Abstract
Objectives. To give an overview on the use and prevalence of clinical pathways.
Design. Cross-sectional descriptive study.
Study participants. European Pathway Association contact persons in 23 countries.
Results. Clinical pathways, also known as critical pathways or integrated-care pathways have been used in health care for 20 years. Although clinical pathways are well established, little information exists on their use and dissemination around the world. The European Pathway Association (www.E-P-A.org) has performed their first international survey on the use and dissemination of clinical pathways in 23 countries. At present, pathways are used with a minority of patients, mainly in acute hospital trusts. Our survey showed that clinical pathways were predominantly viewed as a multidisciplinary tool to improve the quality and efficiency of evidence-based care. Pathways were also used as a communication tool between professionals to manage and standardise outcome-oriented care.
Conclusions. There is a future for the use of clinical pathways, but there is need for international benchmarking and knowledge sharing with regards to their development, implementation, and evaluation.
If you use these results in your papers or presentations, please refer to the survey correctly as:
Kris Vanhaecht, Marcus Bollmann, Kathy Bower, Clare Gallagher, Andrea Gardini, Jen Guezo, Uwe Jansen, Rashad Massoud, Karen Moody, Walter Sermeus, Ruben Van Zelm, Claire Whittle, Anne-Marie Yazbeck, Karen Zander, Massimiliano Panella (2006). Prevalence and use of clinical pathways in 23 countries — an international survey by the European Pathway Association (www.E-P-A.org). Journal of Integrated Care Pathways, 10, 28-34.
|
|
|
|
|
